| Literature DB >> 36048792 |
Kusnanto Kusnanto1, Hidayat Arifin2,3, Rifky Octavia Pradipta1, Gusmaniarti Gusmaniarti4, Heri Kuswanto5, Agus Setiawan6, Bih-O Lee7.
Abstract
Psychological problems commonly experienced by patients with type 2 diabetes mellitus (T2DM) cause diabetes fatigue conditions that can further worsen the treatment prognosis. We conducted this investigation to determine the effectiveness of a resilience-based Islamic program on diabetes fatigue and health-related quality of life (HRQoL) by measuring the biochemical indicators of T2DM. This was a quasi-experimental study performed from May to August 2021, in which 80 respondents aged 18-64 years diagnosed with T2DM were included through purposive sampling at a male:female sex ratio of 1:1 in the control group and 17:23 in the treatment group. A resilience-based Islamic program (a combination of stress management, mindfulness, prayer, and dhikr (the ritual formula of Sufi brotherhood recited devotionally in praise of Allah and as a means of attaining ecstatic experience)) was implemented in the treatment group for six sessions by blended online and offline interventions. Multidimensional Fatigue Inventory-20 and World Health Organization Quality of Life, Brief Form were used to evaluate diabetes fatigue and HRQoL. Blood tests were performed to measure HbA1c, total antioxidant serum, insulin, cholesterol, triglyceride, high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c) levels from baseline to 3 months. Statistical analyses were conducted using paired t test, Wilcoxon signed-rank test, independent t test, and Mann-Whitney U test. The resilience-based Islamic program had a beneficial impact on the levels of HbA1c (p < 0.001), lipid profile (triglyceride) (p = 0.011), HDL-c (p = 0.01), LDL-c (p < 0.001), total antioxidant serum (p = 0.001), insulin (p < 0.001), diabetes fatigue (p < 0.05), and HRQoL (p < 0.05) in patients of the treatment group. The results of biochemical tests related to T2DM also indicated a reduction in diabetes fatigue and an increase in HRQoL due to the resilience-based Islamic program. Considering that a patient's resilience to diabetes is an important factor in the management of diabetes fatigue, the resilience-based Islamic program can be applied at public health centers and community levels to increase T2DM resilience.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36048792 PMCID: PMC9436096 DOI: 10.1371/journal.pone.0273675
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Sample diagram flow chart.
Overview of the resilience based Islamic program.
| Session | Intervention |
|---|---|
|
| Hopes and expectation. Looking at how diabetes fatigue and stress affects thoughts feelings, physical wellbeing, and behavior. Islamic strengthen through five times prayers and dzikr. |
|
| Identifying source of fatigue, distorted thoughts, and moods by understanding anxiety, stress and how we react. |
|
| Challenging distorted thoughts and mood. How we can limit ourselves though habitual negative thoughts and moods. |
|
| Managing stress, anxiety, worry, and panic that caused diabetes fatigue. Strengthen though acceptance, controlling panic, learning how to relax, and importance of doing so. |
|
| Setting goals and challenges. Understanding passive anger and resistance. Learning about comfort zone and panic zones. |
|
| Reviewing learning and planning for the future. |
|
| A different relaxation technique is introduced in each session, including techniques based on mindfulness and Islamic intervention. |
Respondent’s characteristic demography.
| Characteristic | Group |
| |||
|---|---|---|---|---|---|
| Treatment (n = 40) | Control (n = 40) | ||||
| n | % | n | % | ||
|
| |||||
| | 17 | 42.5 | 20 | 50 | 0.200 |
| | 23 | 57.5 | 20 | 50 | |
|
| |||||
| | 5 | 12.5 | 2 | 5 | 0.603 |
| | 20 | 50 | 10 | 25 | |
| | 7 | 17 | 19 | 47.5 | |
| | 8 | 20 | 9 | 22.5 | |
|
| |||||
| | 28 | 70 | 36 | 90 | 0.642 |
| | 10 | 25 | - | - | |
| | 2 | 5 | 4 | 10 | |
|
| |||||
| | 4 | 10 | 15 | 37.5 | 0.638 |
| | 19 | 47.5 | 24 | 60 | |
| | 17 | 42.5 | 1 | 2.5 | |
|
| |||||
| | 18 | 45 | 13 | 32.5 | > 0.999 |
| | 22 | 55 | 27 | 67.5 | |
|
| |||||
| | 23 | 57.5 | 21 | 52.5 | 0.062 |
| | 17 | 42.5 | 19 | 47.5 | |
*Fisher’s exact test; homogeneity p > 0.05
The distribution and analysis of HbA1c, TAS, lipid profile, insulin, diabetes fatigue, and health related quality of life.
| Group | n | Pre-test | Post-test | Difference |
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Min—Max | Median ± IQR | Mean ± SD | Min—Max | Median ± IQR | Mean ± SD | ||||||
|
| ||||||||||||
| | 40 | 6.72 ± 0.67 | 5.2–7.9 | 6.85 ± 0.84 | 6.16 ± 0.77 | 4.8–7.5 | 6.25 ± 1.5 | -0.56 ± 0.1 | 5.91–6.41 | - 0.65 | <0.001 | 0.004 |
| | 40 | 6.58 ± 0.73 | 5.5–7.8 | 6.4 ± 1.3 | 6.62 ± 0.62 | 5.6–7.7 | 6.5 ± 1.0 | 0.04 ± -0.11 | 6.42–6.82 | 0.377 | ||
|
| ||||||||||||
| | 40 | 1.55 ± 0.54 | 0 .6–2.5 | 1.55 ± 0.9 | 1.79 ± 0.49 | 0.9–2.7 | 1.9 ± 0.59 | 0.24 ± -0.05 | 1.63–1.95 | 0.80 | 0.001 | <0.001 |
| | 40 | 1.44 ± 0.58 | 0.5–2.5 | 1.25 ± 0.95 | 1.39 ± 0.50 | 0.7–2.6 | 1.15 ± 0.95 | -0.05 ± -0.08 | 1.22–1.55 | 0.216 | ||
|
| ||||||||||||
|
| ||||||||||||
| | 40 | 211.57 ± 57.85 | 112–350 | 206.0 ± 63.0 | 200.17 ± 44.05 | 112–289 | 200.0 ± 50.5 | -11.4 ± -13.8 | 186.08–214.26 | -0.45 | 0.099 | 0.044 |
| | 40 | 217.25 ± 53.27 | 112–372 | 220.0 ± 53.0 | 220.4 ± 44.28 | 150–321 | 220.0 ± 60.0 | 3.15 ± -8.99 | 206.23–234.56 | 0.649 | ||
|
| ||||||||||||
| | 40 | 163.65 ± 46.31 | 85–273 | 151.5 ± 73.0 | 137.82 ± 27.13 | 89–190 | 132.0 ± 32.5 | -25.83 ± -19.18 | 129.14–146.50 | -0.09 | 0.011 | <0.001 |
| | 40 | 168.27 ± 32.86 | 89–270 | 175.0 ± 42.0 | 166.77 ± 31.62 | 120–250 | 170.0 ± 48 | -1.5 ± -1.24 | 156.65–176.89 | 0.64a | ||
|
| ||||||||||||
| | 40 | 57.2 ± 13.2 | 34–80 | 54.5 ± 21.0 | 67.17 ± 11.16 | 43–88 | 67.5 ± 16.0 | 9.97 ± -2.04 | 63.60–70.74 | 1.07 | 0.01 | <0.001 |
| | 40 | 56.17 ±13.62 | 34–87 | 54.5 ± 22.0 | 55.05 ± 11.41 | 39–77 | 55.5 ± 17.5 | -1.12 ± -2.21 | 51.39–58.70 | 0.339 | ||
|
| ||||||||||||
| | 40 | 116.55 ± 20.53 | 80–154 | 120.0 ± 30.0 | 105.35 ± 19.39 | 80–150 | 100.0 ± 25.0 | -11.2 ± -1.14 | 99.14–111.55 | - 0.56 | <0.001 | 0.014 |
| | 40 | 113.87 ± 20.16 | 80–150 | 116.0 ± 24.5 | 116.2 ± 19.22 | 88–150 | 115.0 ± 30.0 | 2.33 ± -0.94 | 110.05–122.34 | 0.272 | ||
|
| ||||||||||||
| | 40 | 6.31 ± 1.13 | 4.0–8.9 | 6.45 ± 1.4 | 6.96 ± 1.19 | 4.2–9.1 | 7.0 ± 1.9 | 0.65 ± 0.06 | 6.57–7.34 | 1.29 | <0.001 | <0.001 |
| | 40 | 5.54 ± 1.05 | 3.4–7.8 | 5.5± 1.4 | 5.48 ± 1.09 | 3.1–7.4 | 5.65 ± 1.0 | -0.06 ± 0.04 | 5.13–5.82 | 0.954 | ||
|
| ||||||||||||
|
| ||||||||||||
| | 40 | 13.35 ± 1.77 | 9.0–17.0 | 13.0 ± 3.0 | 10.1 ± 2.14 | 6.0–15.0 | 10.0 ± 3.5 | -3.25 ± 0.37 | 9.41–10.78 | - 0.92 | 0.022 | 0.001 |
| | 40 | 11.95 ± 1.73 | 9.0–17.0 | 12.0 ± 3.0 | 12.05 ± 2.06 | 8.0–17.0 | 12.0 ± 4.0 | 0.1 ± 0.33 | 11.39–12.70 | 0.681 | ||
|
| ||||||||||||
| | 40 | 12.07 ± 1.84 | 9.0–16.0 | 12.0 ± 2.0 | 9.62 ± 1.97 | 5.0–15.0 | 9.0 ± 3.0 | -2.45 ± 0.13 | 8.99–10.25 | - 1.22 | <0.001 | <0.001 |
| | 40 | 12.12 ± 2.23 | 8.0–17.0 | 12.0 ± 3.5 | 12.0 ± 1.92 | 8.0–16.0 | 12.0 ± 3.0 | -0.12 ± -0.31 | 11.38–12.61 | 0.49 | ||
|
| ||||||||||||
| | 40 | 12.2 ± 2.28 | 8.0–17.0 | 12.0 ± 4.0 | 9.65 ± 2.63 | 5.0–16.0 | 10.0 ± 3.0 | -2.55 ± 0.35 | 8.80–10.49 | - 0.88 | <0.001 | <0.001 |
| | 40 | 11.25 ± 1.79 | 8.0–17.0 | 11.0 ± 2.0 | 11.6 ± 1.69 | 8.0–15.0 | 11.0 ± 3.0 | 0.35 ± -0.1 | 11.05–12.1 | 0.132 | ||
|
| ||||||||||||
| | 40 | 11.97 ± 2.20 | 8.0–16.0 | 12.0 ± 4.0 | 9.52 ± 2.39 | 5.0–14.0 | 10.0 ± 3.5 | -2.45 ± 0.19 | 8.75–10.29 | - 1.07 | <0.001 | <0.001 |
| | 40 | 11.65 ± 2.48 | 8.0–17.0 | 12.0 ± 4.0 | 11.87 ± 1.98 | 8.0–15.0 | 12.0 ± 3.0 | 0.22 ± -0.5 | 11.23–12.51 | 0.346 | ||
|
| ||||||||||||
| | 40 | 12.0 ± 2.16 | 8.0–16.0 | 12.0 ± 4.0 | 9.7 ± 2.37 | 6.0–15.0 | 9.5 ± 3.5 | -2.3 ± 0.21 | 8.93–10.46 | - 1.20 | 0.024 | <0.001 |
| | 40 | 12.32 ± 2.78 | 8.0–17.0 | 12.0 ± 4.0 | 12.25 ± 1.83 | 8.0–15.0 | 12.5 ± 4.0 | -0.07 ± -0.95 | 11.66–12.83 | 0.783 | ||
|
| ||||||||||||
|
| ||||||||||||
| | 40 | 74.42 ± 11 | 56–94 | 75.0 ± 17.5 | 90.42 ± 13.45 | 56–100 | 100.0 ± 19.0 | 16 ± 2.45 | 86.12–94.72 | 1.84 | <0.001 | <0.001 |
| | 40 | 73.95 ± 12.64 | 56–100 | 72.0 ± 18 | 69.15 ± 9.22 | 56–88 | 69.0 ± 12.0 | -4.8 ± -3.45 | 66.19–72.10 | 0.011 | ||
|
| ||||||||||||
| | 40 | 77.87 ± 13.82 | 56–100 | 78.0 ± 25.0 | 96.62 ± 7.28 | 63–100 | 100.0 ± 6.0 | 18.75 ± -6.54 | 94.29–98.95 | 3.23 | <0.001 | <0.001 |
| | 40 | 70.45 ± 9.37 | 56–94 | 69.0 ± 15.0 | 69.05 ± 9.6 | 56–93 | 69.0 ± 12.0 | -1.4 ± 0.23 | 65.97–72.12 | 0.094 | ||
|
| ||||||||||||
| | 40 | 78.6 ± 13.26 | 56–100 | 78.0 ± 19.0 | 96.25 ± 8.0 | 75–100 | 100.0 ± 0.0 | 17.65 ± -5.26 | 93.68–98.81 | 1.78 | 0.001 | <0.001 |
| | 40 | 77.07 ± 12.18 | 56–100 | 75.0 ± 19.0 | 77.37 ± 12.67 | 56–100 | 75.0 ± 19.0 | 0.3 ± 0.49 | 73.32–81.42 | 0.159 | ||
|
| ||||||||||||
| | 40 | 79.67 ± 14.26 | 44–100 | 81.0 ± 22.0 | 98.2 ± 3.38 | 88–100 | 100.0 ± 3.0 | 18.53 ± -10.88 | 97.11–99.28 | 2.12 | <0.001 | <0.001 |
| | 40 | 73.92 ± 11.54 | 56–94 | 78.0 ± 18.0 | 76.1 ± 14.3 | 56–100 | 75.0 ± 25.0 | 2.18 ± 2.76 | 71.52–80.67 | 0.025 | ||
HbA1c: Glycated Hemoglobin A1c; TAS: Total Antioxidant Serum; HDL-c: High-Density Lipoprotein Cholesterol; LDL-c: Low-Density Lipoprotein Cholesterol; HRQoL: Health Related Quality of Life; SD: Standard Deviation; CI: Confident Interval; d: Cohen’s d coefficient; interquartile range (IQR)
Significant value: p<0.05
p*: intragroup comparison
p**: intergroup comparison
aPaired t-test
bWilcoxon Signed Rank Test
cIndependent t-test
dMann-Whitney U-test